Stratec stock jumped on Thursday after Deutsche Bank upgraded the company's rating to Buy, citing improving earnings visibility and a lower risk profile for the outlook. The shares rose 4.95% to €28.60, approaching a 52-week high of €28.65, while the SDAX benchmark gained roughly 0.2% during the same session.
Deutsche Bank analyst Jan Koch raised his price target to €39 from €21, pointing to three central elements that underpin the altered view: reduced uncertainty around Stratec's 2026 outlook, the anticipated earnings impact of the planned disposal of Diatron, and a recovery in the company’s core instrument business.
"The reset is largely behind us," the brokerage said, arguing that Stratec's financial performance and growth prospects were improving after a difficult period.
The bank said the planned sale of Diatron would materially improve Stratec's earnings profile. It added that a normalization in demand for service parts could offer further upside, and highlighted renewed growth in the core instrument segment as several new platforms near commercialisation.
Koch also noted that the combination of these operational developments, improved cost efficiency and what Deutsche Bank described as more conservative expectations management had produced an attractive risk-reward profile for investors.
The upgrade was issued in the wake of Stratec's latest nine-month results. Revenue from continuing operations fell 5% at constant exchange rates to €164.9 million over that period. Despite the top-line decline, the company's adjusted EBIT margin improved to 8.3% from 7.3% year-over-year, with the third-quarter margin reaching 11.3%.
Looking ahead, Stratec expects 2026 revenue from continuing operations to remain broadly stable or show a slight increase at constant currencies. Management has provided an adjusted EBIT margin target for 2026 of 13% to 15%.
Market reaction to Deutsche Bank’s upgrade was immediate: the stock approached its 52-week high on the day of the announcement, reflecting investor attention on the combination of strategic disposals, service-demand recovery and product commercialisation cited by the analyst.
While Deutsche Bank has raised its price target substantially, the bank’s assessment is tied to the realisation of the Diatron sale, a sustained recovery in instrument sales and the firm delivering on its margin targets.
Investors and market participants will likely watch upcoming operational milestones and any updates on the Diatron disposal closely, as these elements were central to the broker’s view that the company’s reset phase is largely complete and that upside is now more visible.